Portal hypertension

Current Problems in Surgery

Volumn 35, Issue 5, 1998, Pages 389-452

  Michael Henderson, J ^a   Barnes, David S ^a   Geisinger, Michael A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY; DECOMPRESSION SURGERY; ESOPHAGUS; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER TRANSPLANTATION; MORTALITY; PATIENT CARE; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; STOMACH; SURVIVAL RATE; VASCULARIZATION;

ARTERIES; DECOMPRESSION, SURGICAL; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGUS; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER TRANSPLANTATION; PATIENT CARE TEAM; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS; RECURRENCE; STOMACH; SURVIVAL RATE;

EID: 0032067579     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (226)

1. Bryan CP. The papyrus ebers. New York: D Appleton; 1931. p. 134-5.
2. Chen TS, Chen PS. Understanding the liver: a history. Westport, Conn.: Greenwood Press; 1984. p. 151-8.
3. Power W. Contributions to pathology. MD Med Surg J 1840;306-18.
4. Preble KB. Conclusions based on sixty cases of fatal gastrointestinal hemorrhage due to cirrhosis of the liver. Am J Med Sei 1900:119:263-80.
5. Gilbert A, Villaret M. Contribution a l'étude du syndrome d'hypertension portale; cytologie des liquides d'ascite dans les cirrhoses. Comptes Rendus Société de Biologie 1906:60:820-3.
6. Banti G. Dell'anemia splenica. Archivo di Anatomia Normale e Patologica 1883;2: 53-122.
7. Mclndoe AH. Vascular lesions of portal cirrhosis. Arch Pathol 1928;5:23-40.
8. McMichael J. Local vascular changes in splenic anemia. Edinburgh Med J 1931;38: 1-29.
9. Rousselot LM. The role of congestion (portal hypertension) in so-called Banti's syndrome: a clinical and pathologic study of 31 cases with late results following splenectomy. J Am Med Assoc 1936;107:1788-93.
10. Thompson WP, Caughey JL, Whipple AO, et al. Splenic vein pressure in congestive splenomegaly (Banti's syndrome). J Clin Invest 1937:16:571-2.
11. Warren JV, Brannon ES. A method of obtaining blood samples directly from the hepatic vein in man. Proc Soc Exp Biol Med 1994;55:144-6.
12. Freidman EW, Weiner RD. Estimation of hepatic sinusoid pressure by means of venous catheters and estimation of portal pressure by hepatic vein catheterization. Am J Physiol 1951; 165:527-31.
13. Myers JD, Taylor WJ. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest 1951:30:662-6.
14. Groszmann RJ, Glickman M, Blei AT, Storer E, Conn HO. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 1979:76: 253-8.
15. Boyer TD, Triger D. Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle: comparison with wedged hepatic vein pressure. Gastroenterology 1977:72:584-9.
16. Reynolds T, Ito S, Iwatsuki S. Measurement of portal pressure and its clinical application. Am J Med 1970:49:649-57
17. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
18. Merkel C. Bolognesi M, Bellon S. et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992:102:973-9.
19. Lautt WW. Hepatic vasculature: a conceptual review. Gastroenterology 1977:73: 1163-9.
20. Chiandussi L. Greco E, Sardi G, Vaccarino A, Ferraris CM, Curti B. Estimation of hepatic arterial and portal venous blood flow by direct catheterization of the vena porta through the umbilical cord in man. Acta Hepato-Splenologica 1968;15:166-71.
21. Henderson JM, Gilmore GT, Mackay GT, Galloway JR, Dodson TF, Kutner MH. Hemodynamics during liver transplantation: the interactions between cardiac output and portal venous and hepatic arterial flows. Hepatology 1992; 16:715-8.
22. Bradley SE, Ingelfinger FJ, Bradley GP, et al. The estimation of hepatic blood flow in man. J Clin Invest 1945:24:890-7.
23. Turner M, Sherlock S, Steiner R. Splenic venography and intrasplenic pressure measurement in the clinical investigation of the portal venous system. Am J Med 1957:23:846-52.
24. Bierman H, Steinback H, White L, et al. Portai venipuncture: a percutaneous transhepatic approach. Proc Soc Exp Biol Med 1952;79:550-6.
25. Oliver TW, Sones PJ. Hepatic radiology. New York: Macmillan; 1984. p. 243-75.
26. Bolondi L, Gandolfi L, Arienti V, et al. Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology 1982; 142:167-72.
27. Burns P, Taylor K, Blei AT. Doppler flowmetry and portal hypertension. Gastroenterology 1987;92:824-6.
28. Eck NV. On the question of ligature of the portal vein. Voen Med Zh 1877; 130:1-22.
29. Hahn M, Massen O, Nenki M, et al. De ecksche fistel zwischen der unteren hohlvene and der pfortaden und folgen für den Organismus. Archiv für experimentelle Pathologie und Pharmakologie 1893;32:162-210.
30. Banti G. La splenomegalia can cirrosi del fegato. Sperimentale Firenze 1894;447-52.
31. Drummond D, Morison RA. A case of ascites due to liver cirrhosis cured by operation. Br Med J 1896;2:728-9.
32. Talma S. Chirurgische oeffnung neuer Seitenbahnen fur das blut der vena porta. Klin Woschenschr 1898;35:833-6.
33. Vidai E. Traitaient chirurgical des ascites. Presse Med 1903;11:747-61.
34. Crafoord C, Frenckner P. New surgical treatment of varicose veins of the esophagus. Acta Otolaryngol (Stockh) 1939;27:422-9.
35. Johnston GW, Roger HW. A review of 15 years experience in the use of sclerotherapy in the control of acute hemorrhage from esophageal varices. Br J Surg 1973;60: 797-800.
36. Paquet K-J, Oberhammer E. Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy 1978;10:7-12.
37. Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies. Ann Surg 1945; 122:449-56.
38. Warren WD, Zeppa R, Foman JS. Selective transsplenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-55.
39. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989;321 : 1014-22.
40. Steigman GV, Goff JS, Michaletz-Onody P, et al. Endoscopie sclerotherapy as compared with endoscopie variceal ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527-32.
41. Lebrec D, Nouel O, Corbie M, Benhamou JP. Propranolol, a medical treatment for portal hypertension? Lancet 1980;2:180-2.
42. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stentshunt procédure for variceal bleeding. N Engl J Med 1994;330:165-71.
43. Douglass BC, Baggenstoss A, Holinshed W. The anatomy of the portal vein and its tributaries. Surg Gynecol Obstet 1950;91:562-70.
44. Rousselot L, Moreno A, Panke W. Studies on portal hypertension IV: the clinical and physiopathologic significance of self-established (non-surgical) portal venous shunts. Ann Surg 1959; 150:384-96.
45. Lindsay J, Sherlock S. The aetiology, presentation and natural history of extrahepatic portal venous obstruction. Q J Med 1979;48:627-39.
46. Thomas LB, Popper H, Bert PD, Selikoff I, Falk H. Vinyl-chloride-induced liver disease: from idiopathic portal hypertension (Band's syndrome) to angiosarcomas. N Engl J Med 1975;292:17-22.
47. Raia S, Mies S, Macedo AL. Portal hypertension in schistosomiasis. Clin Gastroenterol 1985; 14:57-82.
48. Kerr D, Harrison, Sherlock S, et al. Congenital hepatic fibrosis. Q J Med 1961 ;30: 91-9.
49. Kew MC, Varma RR, Santos HD, Scheuer, PJ. Portal hypertension in primary biliary cirrhosis. Gut 1971;12:830-4.
50. Shaldon S, Sherlock S. Obstruction to the extrahepatic portal system in childhood. Lancet 1962; 1:63-8.
51. Valla D, Casadevall C, Lacombe B. Latent myeloproliferative diseases: a common cause of apparently idiopathic portal vein thrombosis [abstract]. J Hepatol 1986;3: S22.
52. Sutton JP, Yarborough D, Richards D. Isolated splenic vein thrombosis. Arch Surg 1970:100:623-6.
53. Salam AA, Warren WD, Tyras DH. Splenic vein thrombosis: a diagnosable and curable form of portal hypertension. Surgery 1973;74:961-72.
54. Galambos JT. Cirrhosis: major problems in internal medicine. Philadelphia: Saunders; 1979.
55. Budd G. On diseases of the liver. London: John Churchill; 1845.
56. Chiari H. Ueber die selbständige phelbitis oliterans der haupstamme der venae hepaticae als todesurache. Beitr Pathol Anat 1899;26:1.
57. Benoit JN, Granger N. Splanchnic hemodynamics in chronic portal hypertension. Semin Liver Dis 1986;6:287-98.
58. Sikula E. Kravetz D, Groszman RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985;248:G61825.
59. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994;20:1359-63.
60. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776-8.
61. Benoit JN, Womack WA, Hernandez L, Granger DN. "Forward" and "backward" flow mechanisms of portal hypertension. Gastroenterology 1985;89:1092-6.
62. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419-24.
63. Lebrec D, Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139-44.
64. Christensen E, Faverholdt L, Schlichting P, Juhl P, Poulsen H, Tygstrup N. Aspects of natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisolone. Gastroenterology 1981;81:944-52.
65. North Italian Endoscopie Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983-9.
66. Beppu K, Inokuchi K, Koyanagi N, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-8.
67. Lebrec D, De Fluery P, Bueff B, et al. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980;79:1139-40.
68. Cales P. Gastroesophageal endoscopie features in cirrhosis. Gastroenterology 1990; 98:156-62.
69. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
70. Degradia A. The natural history of esophageal varices in patients with alcoholic liver disease. Am J Gastroenterol 1972;72:520-40.
71. Sarin SK, Lahoti D, Saxena SP, Murthy S, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992:16:1343-9.
72. D'Amico G, Montalbano L, Traina M, et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990:99:1558-64.
73. Oliver TW, Sones PH. Hepatic angiography: portal hypertension. In: Bernardino ME, Sones PH. editors. Hepatic radiology. New York: Macmillan; 1984. p.243-75.
74. Child CG. The liver and portal hypertension. Philadelphia: Saunders; 1964. p. 50.
75. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding esophageal varices. Br J Surg 1973:60:646-9.
76. deFranchis R, Pascal JP, Ancona E. et al. Definitions, methodology, and therapeutic strategies in portal hypertension. J Hepatol 1992:15:256-61.
77. Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958:35:190.
78. Terry R. Risks of need biopsy of the liver. Br Med J 1952:1:102.
79. LeBrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982:83:338-40.
80. Gamble P, Colapinto RF, Stronell RD, Colman JC, Blendis L. Transjugular liver biopsy: a review of 461 biopsies. Radiology 1985:157:589-93.
81. Kane M, Krejs G. Complications of diagnostic laparoscopy in Dallas: a 7 year prospective study. Gastrointest Endosc 1984:30:237-40.
82. Branch RA, James JA, Read AE. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease. Clin Pharmacol Ther 1976:20:81-9.
83. Renner E, Wietholtz H, Huguenin P, Arnaud MJ, Preisig R. Caffeine: a model compound for measuring liver function. Hepatology 1984;4:38-46.
84. Oellerich M, Raude E, Burdelski M, et al. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987:25:845-53.
85. Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand 1964:175:281-94.
86. Reichen J. Widmer T, Cotting J. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. Hepatology 1991:14:504-10.
87. Rypins EB, Henderson JM, Fulenwider JT, et al. A tracer method for measuring rate of urea synthesis in normal and cirrhotic subjects. Gastroenterology 1980:78:141924.
88. Leevy CM, Smith F, Longueville J, et al. Indocyanine green clearance as a test for hepatic function: evaluation by dichromatic ear densitometry. J Am Med Assoc 1967:200:236-40.
89. Henderson JM, Kutner MH, Bain RP. First order clearance of plasma galactose: affect of liver disease. Gastroenterology 1982:83:1090-6.
90. Zeeh J, Lange H, Bosche J, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 1988:95:749-59.
91. D'Amico G, Pagliano L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.
92. Reichen J. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Hepatology 1990;11:1066-78.
93. Schwartz SI, Bales HW, Emerson GL, et al. The use of intravenous pituitrin in treatment of bleeding esophageal varices. Surgery 1959:35:45-72.
94. Chojkier M, Groszmann RJ, Atterbury, et al. A controlled comparison of continuous intraarterial and intravenous infusion of vasopressin in hemorrhage from esophageal varices. Gastroenterology 1979;77:540-6.
95. Groszmann RJ, Kravetz D. Bosch, et al. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology 1982;2:757-62.
96. Tsai YT, Lay CS, Lai KH, et al. Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices. Hepatology 1986; 6:406-9.
97. Gimson AES, Westaby D, Hegarty J, Alastair W, Williams R. A randomized trial of vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology 1986:6:410-3.
98. Freeman JG. Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin ("glypressin") versus vasopressin in the early treatment of esophageal varices. Lancet 1982:2:66-8.
99. Valenzuela JE, Schubert T, Fogel RM, et al. A multi-center, randomized, doubleblind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989;10:958-61.
100. Burrough AK, McCormick A, Hughes MD, Sprengers D, D'Heygere F, Mclntyre N. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding: emergency control and prevention of early variceal rebleeding. Gastroenterology 1990:99:1388-95.
101. Hwang JS. Lin CH, Chang CF, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992:16:320-5.
102. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990:99:1401-7.
103. Pasal J. Cales P, Multicenter Study Group. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patient with cirrhosis of the liver and esophageal varices. N Engl J Med 1987;317:856-61.
104. Ideo G. Bellati G, Fesce E, Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology 1988;8:69.
105. Lebrec D. Poynard T, Capron JP, et al. Nadolol for prophylaxis of gastrointestinal bleeding in patient with cirrhosis: a randomized trial. J Hepatol 1988:7:118-25.
106. The Italian Multicenter Project for Propranolol in Prevention of Bleeding. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients: final report of a multicenter randomized trial. J Hepatol 1989:9:75-83.
107. Burroughs AK. Jenkins WJ, Sherlock S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983:309:1539-42.
108. Lebrec D, Poynard T, Bernuau J, et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984;4:355-8.
109. Villeneuve JP, Pomier-Layargues G, Infante-Rivard C, et al. Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology 1986;6: 1239-43.
110. Queuniet AM, Czernichow P, Lerebours E, Durcotte P Tranvouez JL. Colin R. Etude contrôlée due propranolol dans la prevention des récidives hémorragiques chez les patients cirrhotiques. Gastroenterol Clin Biol 1987:11:41-7.
111. Gatta A, Merkel C, Sacerdoti D, et al. Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. Digestion 1987;37:22-8.
112. Colombo M, deFranchis R, Tommasini M, Sangiovanni A, Dioguardi N. B-blockade prevents recurrent gastrointestinal bleeding in well compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. Hepatology 1989;9: 433-8.
113. Sheen IS, Chen TY, Liaw YF. Randomized controlled study of propranolol for the prevention of recurrent esophageal variceal bleeding in patients with cirrhosis. Liver 1989;9:l-5.
114. Garden OJ, Mills P, Birnie GG, Murray GD, Carter DC. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhosis patients. Gastroenterology 1990; 98:185-90.
115. Navasa M, Chesta J, Bosch J, Rodes J. Reduction of portal pressure by isosorbide5-mononitrate in patients with cirrhosis. Gastroenterology 1989:96:1110-8.
116. Ikigami M, Toyonaga A, Tanikawa K. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function. Am J Gastroenterol 1992;87: 1160-4.
117. Angelico M, Carli L, Piat C, et al. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993;104:1460-5.
118. Paquet KJ. Prophylactic endoscopie sclerosing treatment of the esophageal wall in varices: a prospective controlled randomized trial. Endoscopy 1982;l:4-5.
119. Witzel L, Wolberts E, Merki H. Prophylactic endoscopie sclerotherapy of oesophageal varices: a prospective controlled trial. Lancet 1985;l:773-5.
120. Koch H, Henning H, Grimm H, Sohendra N. Prophylactic sclerosing of esophageal varices: results of a prospective controlled study. Endoscopy 1986; 18:40-3.
121. Kobe VE, Zipprich B, Schentke KU, Nilius R. Prophylactic endoscopie sclerotherapy of esophageal varices: a prospective randomized trial. Endoscopy 1990;22:245-8.
122. Santangelo WC, Dueno MI, Estes BL, Krejs GJ. Prophylactic sclerotherapy of large esophageal varices. N Engl J Med 1988;318:814-8.
123. Sauerbruch T, Wotzka R, Kopeke W, et al. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med 1988;319:814.
124. Piai G, Cipolletta L, Claar M, et al. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology 1988; 8:1495-500.
125. Potzi R, Bauer P, Reichel W, Kerstan E, Renner F, Gangl A. Prophylactic sclerotherapy of oesophageal varices in liver cirrhosis: a multicentre prospective controlled randomized trial in Vienna. Gut 1989;30:873-9.
126. Russo A, Giannone G, Magnano A, Passanisi G, Longo C. Prophylactic sclerother-apy in nonalcoholic liver cirrhosis: preliminary results of a prospective controlled randomized trial. World J Surg 1989;13:149-53.
127. Triger DR, Smart HL, Hosking SW, Johnson AG. Prophylactic sclerotherapy for esophageal varices: long term results of a single-center trial. Hepatology 1991;13: 149-53.
128. The Veterans Affairs Cooperative Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in alcoholic liver disease: a randomized, single blind, multicenter clinical trial. N Engl J Med 1991;324:1779-84.
129. deFranchis R, Primignani M, Arcidiacono R, et al. Prophylactic sclerotherapy (ST) in high risk cirrhotics selected by endoscopie criteria: a multicenter randomized controlled trial. Gastroenterology 1991;101:1087-93.
130. Orloff J, Orloff MS, Orloff SL, Rambotti M, Girard B. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995;179:257-72.
131. Sarfeh IJ, Rypins EB. Partial versus total portacaval H-graft diameters. Ann Surg 1986;204:356-62.
132. Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologie portacaval shunt: an experimental study. Radiology 1969;92:1112-4.
133. Rosch J, Hanafee W, Snow H, Barenfus M, Gray R. Transjugular intrahepatic portacaval shunt: an experimental study. Am J Surg 1971; 121:588-92.
134. Guiterrez OH, Burgener FA. Production of nonsurgical portosystemic venous shunts in dogs by transjugular approach. Radiology 1979; 130:507-9.
135. Colapinto RF, Stronell RD, Birch SJ, et al. Creation of an intrahepatic portosystemic shunt with a Gruntzig balloon catheter. Can Med Assoc J 1982; 126:267-8.
136. Colapinto RF, Stronell RD, Gildener M, et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. Am J Roentgenol 1983; 140:709-14.
137. Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portocaval shunt stents: early experience in the dog. Am J Roentgenol 1985;145:8215.
138. Rosch J, Uchida BT, Putman JS, Buschman RW, Law RD, Hershey AL. Experimental intrahepatic portacaval anastomosis: use of expandable Gianturco stents. Radiology 1987;162:481-5.
139. Richter GM, Palmaz JC, Noeldge G, et al. The intrahepatic portosystemic stentshunt: a new nonsurgical percutaneous method. Radiology 1989;114:1511-6.
140. Haskal ZJ, Cope C, Shlansky-Goldberg RD, et al. Transjugular intrahepatic portosystemic shunt related arterial injuries: prospective comparison of large- and small-gauge needle systems. J Vase Interv Radiol 1995;6:911-5.
141. Shultz SR, LaBerge JM, Gordon RL, Warren RS. Anatomy of the portal vein bifurcation: intra versus extrahepatic location: implications for intrahepatic portosystemic shunts. J Vase Interv Radiol 1994;5:457-9.
142. Haskal ZJ, Ring EJ, LaBerge JM, et al. Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension. Radiology 1992;185:813-7.
143. Barton RE, Rosch J, Saxon RR, Lakin PC, Petersen BD, Keller KS. TIPS: short- and long-term results: a survey of 1750 patients. Semin Interv Radiol 1995;12:364-7.
144. Kerlan RK, LaBerge JM, Gordon RL, Ring EJ. Transjugular intrahepatic portosystemic shunts: current status. Am J Roentgenol 1995;164:1059-66.
145. Radosevich PM Ring EJ, LaBerge JM. et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993:186:523-7.
146. Blum U. Haag K, Rossle M, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 1995:195:153-7.
147. Freedman AM, Sanyal AJ, Risnado J, et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographies 1993:13:1185-210.
148. Iwatsuki S, Starzl TE, Todo D. et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988:104:697-705.
149. Wood RP. Shaw BW, Rikkers LF. Liver transplantation for variceal hemorrhage. Surg Clin North Am 1990:70:449-61.
150. Bismuth H, Adams R, Mathur S, Sherlock D. Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era. Am J Surg 1990; 160:105-10.
151. Henderson JM, Gilmore GT, Hooks MA, et al. Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 1992:216:24855.
152. Ringe B, Lang H, Tusch G, Pichlmayr R. Role of liver transplantation in management of esophageal variceal hemorrhage. World J Surg 1994:18:233-9.
153. Jackson FC, Perrin EB, Smith AG, Dagradi AE, Nadal HM. A clinical investigation of the portacaval shunt. II: survival analysis of the prophylactic operation. Am J Surg 1968:115:22-42.
154. Resnick RH, Chalmers TC, Ishihara AM, et al. A controlled trial of the prophylactic portacaval shunt: a final report. Ann Intern Med 1969:70:675-88.
155. Conn HO, Lindenmuth WW. May CJ, Ramsby GR. Prophylactic portacaval anastomosis: a tale of two studies. Medicine 1972:51:27-40
156. Inokuchi K, Cooperative Study Group of Portal Hypertension in Japan. Improved survival after prophylactic portal nondecompressive surgery for esophageal varices: a randomized controlled trial. Hepatology 1990:12:1-6.
157. Helton WC, Belshaw A. Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographie portacaval shunt (TIPS). Am J Surg 1993:165:566-71.
158. Encarnacion CE, Palmaz JC, Rivera FJ, et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vase Interv Radiol 1995:6:687-94.
159. Schyman BM, Berkman JW, Tedesco FJ, Griffin JW Jr, Assad RT. Complications of endoscopie injection sclerotherapy: a review. Am J Gastroenterol 1987:82:823-9.
160. Poison RJ, Westaby D, Gimson AES, et al. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for oesophageal varcies. Hepatology 1989:10:279-83.
161. Laine L, Cook D. Endoscopie ligation compared with sclerotherapy for treatment of esophageal variceal hemorrhage. Ann Intern Med 1995:123:280-7.
162. Villanueva C, Balanzo J, Novella MT. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal bleeding. N Engl J Med 1996:334:1624-9.
163. Coldwell DM, Ring EJ, Rees CR, et al. Multicenter investigation of the role of the transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology 1995; 196:335-40.
164. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugu-lar intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:1143-51.
165. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stentshunt procédure for variceal bleeding. N Engl J Med 1994;330:165-71.
166. Fillmore DJ, Miller FJ, Fox LF, Disario JA, Tietze CC. Transjugular intrahepatic portosystemic shunt: mid-term clinical and angiographie follow-up. J Vase Interv Radiol 1996:7:255-61.
167. Haskal ZJ, Pentecost MJ, Soulen MC, Shlansky-Goldberg RD, Baum RA, Cope C. Transjugular intrahepatic portosystemic shunt stenosi and revision: early and midterm results. Am J Roentgenol 1994; 163:439-44.
168. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vase Interv Radiol 1993; 4:779-86.
169. Saxon RR, Mendel-Hartvig J, Vorless CL, et al. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vase Interv Radiol 1996;7:487-97.
170. Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine. Radiology 1995;196:341-7.
171. Dodd GD, Zajko AB, Orons PD, Martin MS, Eichner LS, Santaguida LA. Detection of transjugular intrahepatic portosystemic shunt dysfunction: value of duplex Doppler sonography. Am J Roentgenol 1995:164:1119-24.
172. Lafortune M, Martinet J, Denys A, et al. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. Am J Roentgenol 1995; 164:997-1001.
173. Foshager MC, Ferrai H, Finlay DE, Castaneda-Zuniga WR, Letourneau JG. Color Doppler sonography of transjugular intrahepatic portosystemic shunts (TIPS). Am J Roentgenol 1994;163:105-11.
174. Koslin DB, Mizutani PA. Noninvasive evaluation of TIPS. Semin Interv Radiol 1995; 12:368-74.
175. Millikan WJ. Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding: ten-year follow up. Ann Surg 1985; 160:67-74.
176. Langer B, Taylor BR, Mackenzie DR, Gilas T, Stone RM, Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-toside portacaval shunt. Gastroenterology 1985;88:424-9.
177. Reichle FA, Fahmy WE, Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg 1979;137:13-21.
178. Fischer JE, Bower RH, Atamian S, Welling R. Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg 1981; 194:531-44.
179. Conn HO, Resnick RF, Grace ND, et al. Distal splenorenal shunt versus portalsystemic shunt: current status of a controlled trial. Hepatology 1981;1:151-60.
180. Harley HAJ, Morgan T, Redeker AG, et al. Results of a randomized trial of end-toside portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology 1986;91:802-9.
181. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Ann Surg 1994:219:353-61.
182. Henderson JM, Kutner MH, Millikan WJ, et al. Endoscopie variceal sclerosis com-pared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis: a prospective randomized trial. Ann Intern Med 1990;112:262-9.
183. Rikkers LF, Jin G, Burnett DA, Buchi KN, Cormier RA. Shunt surgery versus endoscopie sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am JSurg 1993;165:27-33.
184. Spina GP, Santambrogio R, Opocher E, et al. Distal splenorenal shunt versus endoscopie sclerotherapy in prevention of variceal rebleeding. Ann Surg 1990;211:17886.
185. Teres J, Bordas JM, Bravo D, et al. Randomized trial of portacaval shunt, stapling transection and endoscopie sclerotherapy in uncontrolled variceal bleeding. Hepatology 1987;4:159-67.
186. Raia S, deSilva LC, Gayotta LCC, Forster SC, Fukushima J, Strauss E. Portal hypertension in schistosomiasis: a long-term follow up of a randomized trial comparing three types of surgery. Hepatology 1994;20:398-403.
187. Maffei-Faccioli A, Gerunda G, Neri D, et al. Selective variceal decompression and its role relative to other therapies. Am J Surg 1990;211:178-86.
188. Myberg JA. Selective shunts: the Johannesburg experience. Am J Surg 1990;160: 67-74.
189. Orozco H, Mercado HA, Takahashu T, et al. Role of the distal spenorenal shunt in management of variceal bleeding in Latin America. Am J Surg 1990;160:86-9.
190. Ezzat FA, Abu-Elmagd KM, Aly IY, et al. Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis. Ann Surg 1986; 204:566-73.
191. Orloff MJ, Orloff MS, Rambotti M, Girard B. Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg 1992;216:256-68.
192. Stipa S, Balducci G, Ziparo V, Stipa F, Lucandri G. Total shunting and elective management of variceal bleeding. World J Surg 1994; 18:200-4.
193. Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of TIPS versus small diameter prosthetic H graft portacaval shunt in the treatment of bleeding varcies. Ann Surg 1996;224:378-86.
194. Bismuth H, Franco D, Hepp J. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg 1974; 179:209-18.
195. Johansen K. Partial portal decompression for variceal hemorrhage. Am J Surg 1989; 157:479-82.
196. Paquet KJ, Mercado MA, Gad HA. Surgical procedures for bleeding esophagogastric varices when sclerotherapy fails: a prospective study. Am J Surg 1990; 160:43-7.
197. Mercado MA, Morales-Linares JC, Granados-Garcia J, Gomez-MendezTJ, Chan C, Orozco H. Distal splenorenal shunt versus 10 mm low-diameter mesocaval shunt for variceal hemorrhage. Am J Surg 1996;171:591-5.
198. Henderson JM, Warren WD, Millikan WJ, Galloway JR, Kawasaki S, Kutner MH. Distal splenorenal shunt with splenopancreatic disconnection: a four year assessment. Ann Surg 1989;210:332-41.
199. Inokuchi K, Sugimachi K. The selective shunt for variceal bleeding: a personal perspective. Am J Surg 1990; 160:48-53.
200. Idezuki Y, Kakudo N, Sanjo K, Bandai Y. Sugiura procedure for management of variceal bleeding in Japan. World J Surg 1994;18:216-21.
201. Dagenais M, Langer B, Taylor BR, Greig PD. Experience with radical esopha-gogastric devascularization procedures (Sugiura) for variceal bleeding outside Japan. World J Surg 1994;18:222-8.
202. Brems JJ, Hiatt JR, Klein AS, et al. Effect of prior portasystemic shunt on subsequent liver transplantation. Ann Surg 1989;209:51-6,
203. Crass RA, Keeffe EB, Pinson CW. Management of variceal hemorrhage in the potential liver transplant candidate. Am J Surg 1989;157:476-8.
204. Mazzaferro V, Todo S, Tzakis AG, Stieber AC, Makowka L, Starzl TE. Liver transplantation in patients with previous portasystemic shunt. Am J Surg 1990; 160:111-4.
205. Warren WD, Henderson JM, Millikan WJ, Galambos JT, Bryan FC. Management of variceal bleeding in patients with non-cirrhotic portal vein thrombosis. Ann Surg 1988;207:623-34.
206. Howard ER, Stringer MD, Mowat AP. Assessment of injection sclerotherapy in the management of 152 children with esophageal varices. Br J Surg 1988;75:404-8.
207. Clatworthy HW, Wall T, Watman RN. A new type of portal to systemic venous shunt for portal hypertension. Arch Surg 1955;71:588-96.
208. Voorhees AB, Chaitman E, Schneider S, Nicholson JF, Kornfeld S, Price JB Jr. Portal systemic encephalopathy in the non-cirrhotic patient: effect of portal systemic shunt. Arch Surg 1973;107:659-63.
209. Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children: results of surgical portosystemic shunts. J Pediatr 1983; 103: 703-7.
210. Epstein M. Deranged sodium homeostasis in cirrhosis. Gastroenterology 1979;76: 622-35.
211. Arroya V, Gines P, Rodes J. Treatment of ascites in patients with cirrhosis of the liver. J Hepatol 1986;2:504-12.
212. Crenshaw WB, Gordon FD, McEniff NJ, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200:185-92.
213. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites. N Engl J Med 1995;332:1191-7.
214. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709-16.
215. Henderson JM, Warren D, Millikan WJ, et al. Surgical options, hématologie evaluation and pathologic changes in Budd-Chiari syndrome. Am J Surg 1990; 159:41-50.
216. Valla D, Casadevall N, Lacombe C, et al. Primary myeloproliferative disorders and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985;103:329-34.
217. Orloff MJ, Girard B. Long-term results of treatment of Budd-Chiari syndrome by side-to-side portacaval shunt. Surg Gynecol Obstet 1989;168:33-41.
218. McCarthy PM, vanHeerden JA, Adson MA, Schafer LW, Wiesner RH. The BuddChiari syndrome: medical and surgical management of 30 patients. Arch Surg 1985;120:657-62.
219. Cameron JL, Herlong F, Sanfey H, et al. The Budd-Chiari syndrome: treatment by mesenteric-systemic venous shunts. Ann Surg 1983;198:335-46.
220. Pezzuoli G, Spina GP, Opocher E, Galeotti F, Zannini P. Portacaval shunt in the treatment of primary Budd-Chiari syndrome. Surgery 1985;98:319-23.
221. Klein AS, Cameron JL. Diagnosis and management of Budd-Chiari syndrome. Am JSurg 1990:160:128-33.
222. Peltzer MY, Ring EJ. LaBerge JM. Haskal ZJ, Radosevich PM Gordon RL. Treatment of Budd-Chiari syndrome with a transhepatic intrahepatic portosystemic shunt. J Vase Interv Radiol 1993;4:263-7.
223. Blum U. Rossle M, Haag K, et al. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995;197:805-11.
224. Bismuth H, Sherlock DJ. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 1992:214:581-9.
225. Shaked A. Goldstein RM, Klintmalm GB. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992:174: 453-459.
226. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990:211:43-9.